| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-06611SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB500-206SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-25149SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-47945-0.1mg | |||
| IHC-Prediluted | NBP2-48086 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-47950-0.1mg | |||
| IHC-Prediluted | NBP2-48191 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-54591-100ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-2385SS | |||
| Azide and BSA Free | NBP2-80937 | |||
![Immunocytochemistry/Immunofluorescence: CD34 Antibody (4H11[APG]) [NB500-608] - Human chronic myeloid leukemia cell line MOLM-7 with anti-human CD34 (4H11[APG]) PE.](http://images.novusbio.com/fullsize/CD34-Antibody-4H11-APG-Immunocytochemistry-Immunofluorescence-NB500-608-img0003.jpg "Immunocytochemistry/Immunofluorescence: CD34 Antibody (4H11[APG]) [NB500-608] - Human chronic myeloid leukemia cell line MOLM-7 with anti-human CD34 (4H11[APG]) PE.")
![Flow (Cell Surface): CD34 Antibody (4H11[APG]) [NB500-608] - Surface staining of CD34+ cells in human peripheral blood](http://images.novusbio.com/fullsize/CD34-Antibody-4H11-APG-Flow-Cell-Surface-NB500-608-img0010.jpg)
![Flow (Cell Surface): CD34 Antibody (4H11[APG]) [NB500-608] - Analysis using the FITC conjugate of NB500-608. Staining of Kg-1a human acute myelogenous leukemia cell line with anti-human CD34 (4H11[APG]) FITC. Total viable cells were used for analysis.](http://images.novusbio.com/fullsize/CD34-Antibody-4H11-APG-Flow-Cell-Surface-NB500-608-img0002.jpg)
![Flow Cytometry: CD34 Antibody (4H11[APG]) [NB500-608] - Staining of CD34+ cells in human peripheral blood with anti-human CD34 (4H11[APG]) Alexa Fluor® 700.](http://images.novusbio.com/fullsize/CD34-Antibody-4H11-APG-Flow-Cytometry-NB500-608-img0004.jpg)
![Flow (Cell Surface): CD34 Antibody (4H11[APG]) [NB500-608] - Surface staining of CD34+ cells in human peripheral blood with anti-human CD34 (4H11[APG]) Pacific BlueTM](http://images.novusbio.com/fullsize/CD34-Antibody-4H11-APG-Flow-Cell-Surface-NB500-608-img0005.jpg)
![Flow (Cell Surface): CD34 Antibody (4H11[APG]) [NB500-608] - Surface staining of CD34+ cells in human peripheral blood with anti-human CD34 (4H11[APG]) PE-CyTM7.](http://images.novusbio.com/fullsize/CD34-Antibody-4H11-APG-Flow-Cell-Surface-NB500-608-img0006.jpg)
![Flow (Cell Surface): CD34 Antibody (4H11[APG]) [NB500-608] - Surface staining of CD34+ cells in human peripheral blood with anti-human CD34 (4H11[APG]) Alexa Fluor® 488.](http://images.novusbio.com/fullsize/CD34-Antibody-4H11-APG-Flow-Cell-Surface-NB500-608-img0007.jpg)
![Flow (Cell Surface): CD34 Antibody (4H11[APG]) [NB500-608] - Surface staining of CD34+ cells in human peripheral blood with anti-human CD34 (4H11[APG]) APC.](http://images.novusbio.com/fullsize/CD34-Antibody-4H11-APG-Flow-Cell-Surface-NB500-608-img0008.jpg)
![Flow (Cell Surface): CD34 Antibody (4H11[APG]) [NB500-608] - Surface staining of CD34+ cells in human peripheral blood with anti-CD34 (4H11[APG]) biotin / streptavidin-APC.](http://images.novusbio.com/fullsize/CD34-Antibody-4H11-APG-Flow-Cell-Surface-NB500-608-img0009.jpg)
![Western Blot: HLA DR/DP Antibody (SC06-78) [NBP2-67610] - Western blot analysis of HLA DR/DP on Daudi cell lysates. Proteins were transferred to a PVDF membrane and blocked with 5% BSA in PBS for 1 hour at room temperature. The primary antibody (1/500) was used in 5% BSA at room temperature for 2 hours. Goat Ant](http://images.novusbio.com/fullsize/HLA-DR-DP-Antibody-SC06-78-Western-Blot-NBP2-67610-img0013.jpg "Western Blot: HLA DR/DP Antibody (SC06-78) [NBP2-67610] - Western blot analysis of HLA DR/DP on Daudi cell lysates. Proteins were transferred to a PVDF membrane and blocked with 5% BSA in PBS for 1 hour at room temperature. The primary antibody (1/500) was used in 5% BSA at room temperature for 2 hours. Goat Ant")
![Immunocytochemistry/Immunofluorescence: HLA DR/DP Antibody (SC06-78) [NBP2-67610] - Staining HLA-DR in B16-F1 cells (green). The nuclear counter stain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilised with 0.25% Triton X100/PBS.](http://images.novusbio.com/fullsize/HLA-DR-DP-Antibody-SC06-78-Immunocytochemistry-Immunofluorescence-NBP2-67610-img0009.jpg)
![Immunohistochemistry-Paraffin: HLA DR/DP Antibody (SC06-78) [NBP2-67610] - Immunohistochemical analysis of paraffin-embedded human tonsil tissue using anti-HLA DR/DP antibody. The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 8.0-8.4) for 20 minutes. The tissues were blocked in 5% BSA for 30 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ET1610-66, 1/200) for 30 minutes at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX.](http://images.novusbio.com/fullsize/HLA-DR-DP-Antibody-SC06-78-Immunohistochemistry-Paraffin-NBP2-67610-img0012.jpg)
![Flow Cytometry: HLA DR/DP Antibody (SC06-78) [NBP2-67610] - Analysis of Jurkat cells with HLA-DR antibody at 1/50 dilution (red) compared with an unlabelled control (cells without incubation with primary antibody; black). Alexa Fluor 488-conjugated goat anti rabbit IgG was used as the secondary antibody.](http://images.novusbio.com/fullsize/HLA-DR-DP-Antibody-SC06-78-Flow-Cytometry-NBP2-67610-img0001.jpg)
![Western Blot: HLA DR/DP Antibody (SC06-78) [NBP2-67610] - Analysis of HLA-DR on Daudi cells lysates using anti-HLA-DR antibody at 1/1,000 dilution.](http://images.novusbio.com/fullsize/HLA-DR-DP-Antibody-SC06-78-Western-Blot-NBP2-67610-img0008.jpg)
![Immunocytochemistry/Immunofluorescence: HLA DR/DP Antibody (SC06-78) [NBP2-67610] - Staining HLA-DR in Hela cells (green). The nuclear counter stain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilised with 0.25% Triton X100/PBS.](http://images.novusbio.com/fullsize/HLA-DR-DP-Antibody-SC06-78-Immunocytochemistry-Immunofluorescence-NBP2-67610-img0002.jpg)
![Immunohistochemistry-Paraffin: HLA DR/DP Antibody (SC06-78) [NBP2-67610] - Analysis of paraffin-embedded human kidney tissue using anti-HLA-DR antibody. Counter stained with hematoxylin.](http://images.novusbio.com/fullsize/HLA-DR-DP-Antibody-SC06-78-Immunohistochemistry-Paraffin-NBP2-67610-img0003.jpg)
![Immunohistochemistry-Paraffin: HLA DR/DP Antibody (SC06-78) [NBP2-67610] - Analysis of paraffin-embedded human liver tissue using anti-HLA-DR antibody. Counter stained with hematoxylin.](http://images.novusbio.com/fullsize/HLA-DR-DP-Antibody-SC06-78-Immunohistochemistry-Paraffin-NBP2-67610-img0004.jpg)
![Immunohistochemistry-Paraffin: HLA DR/DP Antibody (SC06-78) [NBP2-67610] - Analysis of paraffin-embedded human spleen tissue using anti-HLA-DR antibody. Counter stained with hematoxylin.](http://images.novusbio.com/fullsize/HLA-DR-DP-Antibody-SC06-78-Immunohistochemistry-Paraffin-NBP2-67610-img0005.jpg)
![Immunohistochemistry-Paraffin: HLA DR/DP Antibody (SC06-78) [NBP2-67610] - Analysis of paraffin-embedded human tonsil tissue using anti-HLA-DR antibody. Counter stained with hematoxylin.](http://images.novusbio.com/fullsize/HLA-DR-DP-Antibody-SC06-78-Immunohistochemistry-Paraffin-NBP2-67610-img0006.jpg)
![Immunohistochemistry-Paraffin: HLA DR/DP Antibody (SC06-78) [NBP2-67610] - Analysis of paraffin-embedded mouse kidney tissue using anti-HLA-DR antibody. Counter stained with hematoxylin.](http://images.novusbio.com/fullsize/HLA-DR-DP-Antibody-SC06-78-Immunohistochemistry-Paraffin-NBP2-67610-img0007.jpg)
![Immunohistochemistry-Paraffin: HLA DR/DP Antibody (SC06-78) [NBP2-67610] - Immunohistochemical analysis of paraffin-embedded human liver tissue using anti-HLA DR/DP antibody. The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 8.0-8.4) for 20 minutes. The tissues were blocked in 5% BSA for 30 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ET1610-66, 1/200) for 30 minutes at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX.](http://images.novusbio.com/fullsize/HLA-DR-DP-Antibody-SC06-78-Immunohistochemistry-Paraffin-NBP2-67610-img0010.jpg)
![Immunohistochemistry-Paraffin: HLA DR/DP Antibody (SC06-78) [NBP2-67610] - Immunohistochemical analysis of paraffin-embedded human spleen tissue using anti-HLA DR/DP antibody. The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 8.0-8.4) for 20 minutes. The tissues were blocked in 5% BSA for 30 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ET1610-66, 1/200) for 30 minutes at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX.](http://images.novusbio.com/fullsize/HLA-DR-DP-Antibody-SC06-78-Immunohistochemistry-Paraffin-NBP2-67610-img0011.jpg)
![Western Blot: CD45RA Antibody (MEM-56) [NB500-329] - Fig. 1. Western Blotting analysis of whole cell lysate of HUT-78 human cutaneous T cell lymphoma cell line. Lane 1: immunostaining with anti-human CD4 degrees Control antibody Lane 2: immunostaining with anti-human CD45RA (MEM-56); sample of cell lysate prepared under non-reducing conditions Lane 3: immunostaining with anti-human CD45RA (MEM-56); sample of cell lysate prepared under reducing conditions.](http://images.novusbio.com/fullsize/CD45RA-Antibody-MEM-56-Western-Blot-NB500-329-img0002.jpg "Western Blot: CD45RA Antibody (MEM-56) [NB500-329] - Fig. 1. Western Blotting analysis of whole cell lysate of HUT-78 human cutaneous T cell lymphoma cell line. Lane 1: immunostaining with anti-human CD4 degrees Control antibody Lane 2: immunostaining with anti-human CD45RA (MEM-56); sample of cell lysate prepared under non-reducing conditions Lane 3: immunostaining with anti-human CD45RA (MEM-56); sample of cell lysate prepared under reducing conditions.")
![Flow Cytometry: CD45RA Antibody (MEM-56) [NB500-329] - Staining of human peripheral blood with anti-CD45RA (MEM-56) PE.](http://images.novusbio.com/fullsize/CD45RA-Antibody-MEM-56-Flow-Cytometry-NB500-329-img0011.jpg)
![Flow Cytometry: CD45RA Antibody (MEM-56) [NB500-329] - Surface staining (mass cytometry) of human peripheral blood with anti-CD45RA (MEM-56) 163Dy. Gated on singlets.](http://images.novusbio.com/fullsize/CD45RA-Antibody-MEM-56-Flow-Cytometry-NB500-329-img0001.jpg)
![Flow Cytometry: CD45RA Antibody (MEM-56) [NB500-329] - Using the PerCP direct conjugate Surface staining of human peripheral blood with anti-CD45RA (MEM-56) PerCP.](http://images.novusbio.com/fullsize/CD45RA-Antibody-MEM-56-Flow-Cytometry-NB500-329-img0003.jpg)
![Flow Cytometry: CD45RA Antibody (MEM-56) [NB500-329] - Staining of human peripheral blood with anti-CD45RA (MEM-56) PE-CyTM7.](http://images.novusbio.com/fullsize/CD45RA-Antibody-MEM-56-Flow-Cytometry-NB500-329-img0004.jpg)
![Flow Cytometry: CD45RA Antibody (MEM-56) [NB500-329] - Staining of human peripheral blood with anti-CD45RA (MEM-56) biotin / streptavidin-APC.](http://images.novusbio.com/fullsize/CD45RA-Antibody-MEM-56-Flow-Cytometry-NB500-329-img0005.jpg)
![Flow Cytometry: CD45RA Antibody (MEM-56) [NB500-329] - Staining of human peripheral blood with anti-CD45RA (MEM-56) APC.](http://images.novusbio.com/fullsize/CD45RA-Antibody-MEM-56-Flow-Cytometry-NB500-329-img0006.jpg)
![Flow Cytometry: CD45RA Antibody (MEM-56) [NB500-329] - Staining of human peripheral blood with anti-CD45RA (MEM-56) Pacific OrangeTM.](http://images.novusbio.com/fullsize/CD45RA-Antibody-MEM-56-Flow-Cytometry-NB500-329-img0007.jpg)
![Flow Cytometry: CD45RA Antibody (MEM-56) [NB500-329] - Staining of human peripheral blood with anti-CD45RA (MEM-56) FITC.](http://images.novusbio.com/fullsize/CD45RA-Antibody-MEM-56-Flow-Cytometry-NB500-329-img0008.jpg)
![Flow Cytometry: CD45RA Antibody (MEM-56) [NB500-329] - Staining of human peripheral blood with anti-CD45RA (MEM-56) PE-DyLight® 594.](http://images.novusbio.com/fullsize/CD45RA-Antibody-MEM-56-Flow-Cytometry-NB500-329-img0009.jpg)
![Flow Cytometry: CD45RA Antibody (MEM-56) [NB500-329] - Staining of human peripheral blood with anti-CD45RA (MEM-56) Pacific BlueTM.](http://images.novusbio.com/fullsize/CD45RA-Antibody-MEM-56-Flow-Cytometry-NB500-329-img0010.jpg)
![Western Blot: ATOX1 Antibody [NBP1-06611] - HeLa whole cell extract.](http://images.novusbio.com/fullsize/ATOX1-Antibody-Western-Blot-NBP1-06611-img0005.jpg "Western Blot: ATOX1 Antibody [NBP1-06611] - HeLa whole cell extract.")
![Immunocytochemistry/Immunofluorescence: ATOX1 Antibody [NBP1-06611] - ATOX1 antibody was tested in HeLa cells with Dylight 488 (green). Nuclei and alpha-tubulin were counterstained with DAPI (blue) and Dylight 550 (red).](http://images.novusbio.com/fullsize/ATOX1-Antibody-Immunocytochemistry-Immunofluorescence-NBP1-06611-img0001.jpg)
![Western Blot: Caspase-7 Antibody (Mch3 1-1-11) [NB500-206] - Western blot shows lysates of A549 human lung epithelial parental cell line and Caspase-7 knockout (KO) A549 cell line. PVDF membrane was probed with 1:500 of Mouse Anti-Human Caspase-7 Monoclonal Antibody (Catalog # NB500-106) followed by HRP-conjugated Anti-Mouse IgG Secondary Antibody (Catalog #HAF018). Specific band was detected for Caspase-7 at approximately 40 kDa (as indicated) in the parental A549 cell line, but is not detectable in the knockout A549 cell line. This experiment was conducted under reducing conditions.](http://images.novusbio.com/fullsize/Caspase-7-Antibody-Mch3-1-1-11-Knockdown-Validated-NB500-206-img0004.jpg "<b>Genetic Strategies Validation. </b>Western Blot: Caspase-7 Antibody (Mch3 1-1-11) [NB500-206] - Western blot shows lysates of A549 human lung epithelial parental cell line and Caspase-7 knockout (KO) A549 cell line. PVDF membrane was probed with 1:500 of Mouse Anti-Human Caspase-7 Monoclonal Antibody (Catalog # NB500-106) followed by HRP-conjugated Anti-Mouse IgG Secondary Antibody (Catalog #HAF018). Specific band was detected for Caspase-7 at approximately 40 kDa (as indicated) in the parental A549 cell line, but is not detectable in the knockout A549 cell line. This experiment was conducted under reducing conditions.")
![<b>Genetic Strategies Validation. </b>Western Blot: Caspase-7 Antibody (Mch3 1-1-11) [NB500-206] - HeLa whole cell lysate.](http://images.novusbio.com/fullsize/Caspase-7-Antibody-Mch3-1-1-11-Western-Blot-NB500-206-img0002.jpg)
![Simple Western: Caspase-7 Antibody (Mch3 1-1-11) [NB500-206] - Simple Western lane view shows a specific band for Caspase 7 in 0.5 mg/ml of HeLa lysate. This experiment was performed under reducing A246 conditions using the 12-230 kDa separation system.](http://images.novusbio.com/fullsize/Caspase-7-Antibody-Mch3-1-1-11-Simple-Western-NB500-206-img0003.jpg)
![Western Blot: HSP27 Antibody (6H11) [NBP2-25149] - Western blot shows lysates of HeLa human cervical epithelial carcinoma parental cell line and HSP27 knockout (KO) HeLa cell line. PVDF membrane was probed with 1:5,000 of Mouse Anti-Human HSP27 Monoclonal Antibody (Catalog # NBP2-25149) followed by HRP-conjugated Anti-Mouse IgG Secondary Antibody (catalog number HAF018). Specific band was detected for HSP27 at approximately 27 kDa (as indicated) in the parental HeLa cell line, but is not detectable in the knockout HeLa cell line. This experiment was conducted under reducing conditions.](http://images.novusbio.com/fullsize/HSP27-Antibody-6H11-Knockout-Validated-NBP2-25149-img0006.jpg "<b>Genetic Strategies Validation. </b>Western Blot: HSP27 Antibody (6H11) [NBP2-25149] - Western blot shows lysates of HeLa human cervical epithelial carcinoma parental cell line and HSP27 knockout (KO) HeLa cell line. PVDF membrane was probed with 1:5,000 of Mouse Anti-Human HSP27 Monoclonal Antibody (Catalog # NBP2-25149) followed by HRP-conjugated Anti-Mouse IgG Secondary Antibody (catalog number HAF018). Specific band was detected for HSP27 at approximately 27 kDa (as indicated) in the parental HeLa cell line, but is not detectable in the knockout HeLa cell line. This experiment was conducted under reducing conditions.")
![<b>Genetic Strategies Validation. </b>Western Blot: HSP27 Antibody (6H11) [NBP2-25149] - Analysis of tissue or whole cell lysates using mouse mAb to HSP27, NBP2-25149, dilution 1:10,000, in green. [1] protein standard (red), [2] rat brain, [3] mouse brain, [4] NIH-3T3, [5] HEK293, [6] HeLa, [7] SH-SY5Y cells. The strong single band at ~27 kDa corresponds to the HSP27 protein, detected only in human cell lines, since this antibody is human specific and unreactive with rodent HSP27. The blot was simultaneously probed with rabbit pAb to HSP-60, dilution 1:5,000 in red. A strong 60 kDa band is present in all preparations.](http://images.novusbio.com/fullsize/HSP27-Antibody-6H11-Western-Blot-NBP2-25149-img0007.jpg)
![Immunocytochemistry/Immunofluorescence: HSP27 Antibody (6H11) [NBP2-25149] - Analysis of HeLa cells stained with mouse HSP27 mAb, dilution 1:2000 (Green), and costained with chicken HSP60 pAb, dilution 1:2000 (Red). DAPI staining of nuclear DNA (Blue). The HSP27 antibody produces strong cytoplasm staining, while the HSP60 antibody specifically labels mitochondria](http://images.novusbio.com/fullsize/HSP27-Antibody-6H11-Immunocytochemistry-Immunofluorescence-NBP2-25149-img0008.jpg)
![Flow Cytometry: Hsp27 Antibody (6H11) [NBP2-25149] - Flow cytometric staining of 1 x 10^6 MCF-7 cells using Hsp27 antibody (dark blue). Isotype control shown in orange. An antibody concentration of 1 ug/1x10^6 cells was used.](http://images.novusbio.com/fullsize/Hsp27-Antibody-6H11-Flow-Cytometry-NBP2-25149-img0005.jpg)
![Immunocytochemistry/Immunofluorescence: Hsp27 Antibody (6H11) [NBP2-25149] - HeLa cells stained with NBP2-25149 (red), and counterstained with chicken polyclonal antibody to Vimentin NB300-223 (green) and DNA (blue). NBP2-25149 reveals strong cytoplasmic staining and penetrates into the Actin rich ruffled margins, while the Vimentin antibody reveals cytoplasmic intermediate filaments.](http://images.novusbio.com/fullsize/Hsp27-Antibody-6H11-Immunocytochemistry-Immunofluorescence-NBP2-25149-img0003.jpg)
![Western Blot: Cytokeratin 19 Antibody (KRT19/799) [NBP2-44826] - Western Blot Analysis of human Hep-G2 cell lysate using Cytokeratin 19 Antibody (KRT19/799).](http://images.novusbio.com/fullsize/Cytokeratin-19-Antibody-KRT19-799-Western-Blot-NBP2-44826-img0009.jpg "Western Blot: Cytokeratin 19 Antibody (KRT19/799) [NBP2-44826] - Western Blot Analysis of human Hep-G2 cell lysate using Cytokeratin 19 Antibody (KRT19/799).")
![Immunocytochemistry/Immunofluorescence: Cytokeratin 19 Antibody (KRT19/799) [NBP2-44826] - ICC/IF analysis of MCF-7 cells labeling Cytokeratin 19 with Conjugated with CF488 (Green). The nuclear counterstain is Red Dot (Red)](http://images.novusbio.com/fullsize/Cytokeratin-19-Antibody-KRT19-799-Immunofluorescence-NBP2-44826-img0008.jpg)
![Immunohistochemistry-Paraffin: Cytokeratin 19 Antibody (KRT19/799) [NBP2-44826] - Human Pancreas stained with Cytokeratin 19 Monoclonal Antibody (KRT19/799)](http://images.novusbio.com/fullsize/Cytokeratin-19-Antibody-KRT19-799-Immunohistochemistry-Paraffin-NBP2-44826-img0005.jpg)
![Flow Cytometry: Cytokeratin 19 Antibody (KRT19/799) [NBP2-44826] - Flow Cytometric Analysis of MeOH-fixed MCF-7 cells using Cytokeratin 19 Antibody (KRT19/799) followed by Goat anti-Mouse IgG-CF488 (Blue); Isotype Control (Red).](http://images.novusbio.com/fullsize/Cytokeratin-19-Antibody-KRT19-799-Flow-Cytometry-NBP2-44826-img0007.jpg)
![Immunohistochemistry-Paraffin: Cytokeratin 19 Antibody (KRT19/799) [NBP2-44826] - Human Bladder Carcinoma stained with Cytokeratin 19 Monoclonal Antibody (KRT19/799)](http://images.novusbio.com/fullsize/Cytokeratin-19-Antibody-KRT19-799-Immunohistochemistry-Paraffin-NBP2-44826-img0001.jpg)
![Immunohistochemistry-Paraffin: Cytokeratin 19 Antibody (KRT19/799) [NBP2-44826] - Human Cervical Carcinoma stained with Cytokeratin 19 Monoclonal Antibody (KRT19/799)](http://images.novusbio.com/fullsize/Cytokeratin-19-Antibody-KRT19-799-Immunohistochemistry-Paraffin-NBP2-44826-img0002.jpg)
![Immunohistochemistry-Paraffin: Cytokeratin 19 Antibody (KRT19/799) [NBP2-44826] - Human Endometrial Carcinoma stained with Cytokeratin 19 Monoclonal Antibody (KRT19/799)](http://images.novusbio.com/fullsize/Cytokeratin-19-Antibody-KRT19-799-Immunohistochemistry-Paraffin-NBP2-44826-img0003.jpg)
![Immunohistochemistry-Paraffin: Cytokeratin 19 Antibody (KRT19/799) [NBP2-44826] - Human Ovarian Carcinoma stained with Cytokeratin 19 Monoclonal Antibody (KRT19/799)](http://images.novusbio.com/fullsize/Cytokeratin-19-Antibody-KRT19-799-Immunohistochemistry-Paraffin-NBP2-44826-img0004.jpg)
![Western Blot: MafG Antibody [NBP2-15019] - Various whole cell extracts (30 ug) were separated by 15% SDS-PAGE, and the membrane was blotted with MAFG antibody diluted at 1:1000.](http://images.novusbio.com/fullsize/MafG-Antibody-Western-Blot-NBP2-15019-img0015.jpg "Western Blot: MafG Antibody [NBP2-15019] - Various whole cell extracts (30 ug) were separated by 15% SDS-PAGE, and the membrane was blotted with MAFG antibody diluted at 1:1000.")
![Immunohistochemistry-Paraffin: MafG Antibody [NBP2-15019] - PC9 xenograft, using MAFG antibody at 1:500 dilution. Antigen Retrieval: Trilogy™ (EDTA based, pH 8.0) buffer, 15min.](http://images.novusbio.com/fullsize/MAFG-Antibody-Immunohistochemistry-Paraffin-NBP2-15019-img0002.jpg)
![Immunoprecipitation: MafG Antibody [NBP2-15019] - Immunoprecipitation of MAFG protein from HeLa whole cell extracts using 5 ug of MAFG antibody. Western blot analysis was performed using MAFG antibody EasyBlot anti-Mouse IgG was used as a secondary reagent.](http://images.novusbio.com/fullsize/MafG-Antibody-Immunoprecipitation-NBP2-15019-img0009.jpg)
![Western Blot: MafG Antibody [NBP2-15019] - Various tissue extracts (50 ug) were separated by 15% SDS-PAGE, and the membrane was blotted with MafG antibody (NBP2-15019) diluted at 1:1000. The HRP-conjugated anti-rabbit IgG antibody was used to detect the primary antibody.](http://images.novusbio.com/fullsize/nbp2-15019_rabbit-polyclonal-mafg-antibody-910202420104474.jpg)
![Western Blot: Lamin A + C Antibody [NBP2-19323] - Wild-type (WT) and Lamin A + C knockout (KO) HeLa cell extracts (30 ug) were separated by 7.5% SDS-PAGE, and the membrane was blotted with Lamin A + C antibody. HRP-conjugated anti-rabbit IgG antibody was used to detect the primary antibody, and the signal was developed with Trident ECL plus-Enhanced.](http://images.novusbio.com/fullsize/Lamin-A-+-C-Antibody-Western-Blot-NBP2-19323-img0004.jpg "<b>Genetic Strategies Validation. </b>Western Blot: Lamin A + C Antibody [NBP2-19323] - Wild-type (WT) and Lamin A + C knockout (KO) HeLa cell extracts (30 ug) were separated by 7.5% SDS-PAGE, and the membrane was blotted with Lamin A + C antibody. HRP-conjugated anti-rabbit IgG antibody was used to detect the primary antibody, and the signal was developed with Trident ECL plus-Enhanced.")
![<b>Genetic Strategies Validation. </b>Immunohistochemistry-Paraffin: Lamin A + C Antibody [NBP2-19323] - Paraffin-embedded human breast carcinoma. Lamin A + C antibody dilution: 1:500.](http://images.novusbio.com/fullsize/Lamin-A-+-C-Antibody-Immunohistochemistry-Paraffin-NBP2-19323-img0012.jpg)
![Immunohistochemistry-Paraffin: Lamin A + C Antibody [NBP2-19323] - Lamin A/C antibody detects LMNA protein at membrane on U87 xenograft by immunohistochemical analysis. Sample: Paraffin-embedded U87 xenograft. Lamin A/C antibody dilution: 1:500.](http://images.novusbio.com/fullsize/Lamin-A-+-C-Antibody-Immunohistochemistry-Paraffin-NBP2-19323-img0002.jpg)
![Immunohistochemistry-Paraffin: Lamin A + C Antibody [NBP2-19323] - Paraffin-embedded mouse prostate. Lamin A + C antibody dilution: 1:500.](http://images.novusbio.com/fullsize/Lamin-A-+-C-Antibody-Immunohistochemistry-Paraffin-NBP2-19323-img0007.jpg)
![Immunohistochemistry-Paraffin: Lamin A + C Antibody [NBP2-19323] - Paraffin-embedded mouse fore brain. Lamin A + C antibody dilution: 1:500.](http://images.novusbio.com/fullsize/Lamin-A-+-C-Antibody-Immunohistochemistry-Paraffin-NBP2-19323-img0008.jpg)
![Immunohistochemistry-Paraffin: Lamin A + C Antibody [NBP2-19323] - Paraffin-embedded mouse skin. Lamin A + C antibody dilution: 1:500.](http://images.novusbio.com/fullsize/Lamin-A-+-C-Antibody-Immunohistochemistry-Paraffin-NBP2-19323-img0009.jpg)
![Immunohistochemistry-Paraffin: Lamin A + C Antibody [NBP2-19323] - Paraffin-embedded human endometrial carcinoma. Lamin A + C antibody dilution: 1:500.](http://images.novusbio.com/fullsize/Lamin-A-+-C-Antibody-Immunohistochemistry-Paraffin-NBP2-19323-img0011.jpg)
![Western Blot: Vimentin Antibody (VM1170) [NBP2-44833] - Western Blot Analysis of HEP2 cell lysate using Vimentin Antibody (VM1170).](http://images.novusbio.com/fullsize/Vimentin-Antibody-VM1170-Western-Blot-NBP2-44833-img0008.jpg "Western Blot: Vimentin Antibody (VM1170) [NBP2-44833] - Western Blot Analysis of HEP2 cell lysate using Vimentin Antibody (VM1170).")
![Immunohistochemistry-Paraffin: Vimentin Antibody (VM1170) [NBP2-44833] - Formalin-fixed, paraffin-embedded human Leiomyosarcoma stained with Vimentin Antibody (VM1170).](http://images.novusbio.com/fullsize/Vimentin-Antibody-VM1170-Immunohistochemistry-Paraffin-NBP2-44833-img0007.jpg)
![Immunohistochemistry-Paraffin: Vimentin Antibody (VM1170) [NBP2-44833] - Human Angiosarcoma stained with Vimentin Monoclonal Antibody (VM1170).](http://images.novusbio.com/fullsize/Vimentin-Antibody-VM1170-Immunohistochemistry-Paraffin-NBP2-44833-img0001.jpg)
![Immunohistochemistry-Paraffin: Vimentin Antibody (VM1170) [NBP2-44833] - Human Ewing's Sarcoma stained with Vimentin Monoclonal Antibody (VM1170).](http://images.novusbio.com/fullsize/Vimentin-Antibody-VM1170-Immunohistochemistry-Paraffin-NBP2-44833-img0002.jpg)
![Immunohistochemistry-Paraffin: Vimentin Antibody (VM1170) [NBP2-44833] - Human Leiomyosarcoma stained with Vimentin Monoclonal Antibody (VM1170).](http://images.novusbio.com/fullsize/Vimentin-Antibody-VM1170-Immunohistochemistry-Paraffin-NBP2-44833-img0003.jpg)
![Immunohistochemistry-Paraffin: Vimentin Antibody (VM1170) [NBP2-44833] - Human Melanoma stained with Vimentin Monoclonal Antibody (VM1170).](http://images.novusbio.com/fullsize/Vimentin-Antibody-VM1170-Immunohistochemistry-Paraffin-NBP2-44833-img0004.jpg)
![Immunohistochemistry-Paraffin: Vimentin Antibody (VM1170) [NBP2-44833] - Human Rhabdomyosarcoma stained with Vimentin Monoclonal Antibody (VM1170).](http://images.novusbio.com/fullsize/Vimentin-Antibody-VM1170-Immunohistochemistry-Paraffin-NBP2-44833-img0005.jpg)
![Immunohistochemistry-Paraffin: Vimentin Antibody (VM1170) [NBP2-44833] - Human Uterus stained with Vimentin Monoclonal Antibody (VM1170).](http://images.novusbio.com/fullsize/Vimentin-Antibody-VM1170-Immunohistochemistry-Paraffin-NBP2-44833-img0006.jpg)
![Immunocytochemistry/Immunofluorescence: CD20 Antibody (rIGEL/773) [NBP2-53190] - Immunofluorescence staining of Raji cells using CD20 Antibody (rIGEL/773) followed by goat anti-Mouse IgG conjugated to CF488 (green). Nuclei are stained with Red Dot.](http://images.novusbio.com/fullsize/CD20-Antibody-rIGEL-773-Immunocytochemistry-Immunofluorescence-NBP2-53190-img0004.jpg "Immunocytochemistry/Immunofluorescence: CD20 Antibody (rIGEL/773) [NBP2-53190] - Immunofluorescence staining of Raji cells using CD20 Antibody (rIGEL/773) followed by goat anti-Mouse IgG conjugated to CF488 (green). Nuclei are stained with Red Dot.")
![Immunohistochemistry-Paraffin: CD20 Antibody (rIGEL/773) [NBP2-53190] - Formalin-fixed, paraffin-embedded human lymph node stained with CD20 Antibody (rIGEL/773).](http://images.novusbio.com/fullsize/CD20-Antibody-rIGEL-773-Immunohistochemistry-Paraffin-NBP2-53190-img0006.jpg)
![Flow Cytometry: CD20 Antibody (rIGEL/773) [NBP2-53190] - Flow Cytometric Analysis of Raji cells using CD20 Antibody (rIGEL/773) followed by Goat anti-Mouse IgG-CF488 (Blue); Isotype Control (Red).](http://images.novusbio.com/fullsize/CD20-Antibody-rIGEL-773-Flow-Cytometry-NBP2-53190-img0003.jpg)
![Immunohistochemistry-Paraffin: CD20 Antibody (rIGEL/773) [NBP2-53190] - Formalin-fixed, paraffin-embedded human Tonsil stained with CD20 Recombinant Mouse Monoclonal Antibody (rIGEL/773).](http://images.novusbio.com/fullsize/CD20-Antibody-rIGEL-773-Immunohistochemistry-Paraffin-NBP2-53190-img0002.jpg)
![Immunohistochemistry-Paraffin: CD20 Antibody (rIGEL/773) [NBP2-53190] - Formalin-fixed, paraffin-embedded human tonsil stained with CD20 Antibody (rIGEL/773).](http://images.novusbio.com/fullsize/CD20-Antibody-rIGEL-773-Immunohistochemistry-Paraffin-NBP2-53190-img0005.jpg)
![Protein Array: CD20 Antibody (rIGEL/773) [NBP2-53190] - Analysis of Protein Array containing more than 19,000 full-length human proteins using CD20 Antibody (rIGEL/773).](http://images.novusbio.com/fullsize/CD20-Antibody-rIGEL-773-Protein-Array-NBP2-53190-img0007.jpg)
![Western Blot: S-arrestin Antibody (PDS-1) [NB100-2385] - Western blot analysis of Visual Arrestin expression in human retina tissue extract.](http://images.novusbio.com/fullsize/S-arrestin-Antibody-PDS-1-Western-Blot-NB100-2385-img0004.jpg "Western Blot: S-arrestin Antibody (PDS-1) [NB100-2385] - Western blot analysis of Visual Arrestin expression in human retina tissue extract.")
![Immunohistochemistry-Paraffin: S-arrestin Antibody (PDS-1) [NB100-2385] - S-arrestin was detected in immersion fixed paraffin-embedded sections of human prostate cancer using Mouse Anti-Human S-arrestin (PDS-1) Monoclonal Antibody (Catalog # NB100-2385) at 1:300 for 1 hour at room temperature followed by incubation with the Anti-Mouse IgG VisUCyte™ HRP Polymer Antibody (Catalog # VC001). Tissue was stained using DAB (brown) and counterstained with hematoxylin (blue). Specific staining was localized to the cytoplasm.](http://images.novusbio.com/fullsize/S-arrestin-Antibody-PDS-1-Immunohistochemistry-Paraffin-NB100-2385-img0005.jpg)